Navigation Links
HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
Date:10/15/2008

keter of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, regulatory approvals, competitive offerings, product performance and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Calif. , Aug. 3, 2015  CytomX, ... treatment of cancer, today announced the promotion of ... Debanjan Ray , who previously served as ... has been promoted to senior vice president of ... Mr. Ray held positions as the vice president ...
(Date:8/3/2015)...  Celsion Corporation (NASDAQ: CLSN ) announced ... call to discuss its second quarter 2015 financial ... programs for ThermoDox®, its proprietary heat-activated liposomal encapsulation ... TheraPlas™ and TheraSilence™, in immunotherapy and RNA delivery ... 2015. To participate in the call, interested parties ...
(Date:8/3/2015)... 3, 2015 Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: ... Daniel Teper , will present live at VirtualInvestorConferences.com on ... TIME:   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... event where investors are invited to ask the company ... as well as the association,s "virtual trade booth." If ...
Breaking Medicine Technology:CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2
... Nov. 29, 2011 Millstone Medical Outsourcing announced ... and cold chain distribution services for customers, biologic ... Memphis operation is already a Federal Drug Administration ... authorized to store and distribute human tissue and ...
... 2011  Proventix Systems, Inc., today announced its nGage™ ... hand hygiene monitoring system in the United States.  ... total hand cleansings. Hospitals have experienced ... dispenses since implementation of the Proventix monitoring system. ...
Cached Medicine Technology:Millstone Medical Outsourcing Adds Freezer Storage, Cold Chain Shipment Capabilities for Biologic Products 2Proventix's nGage™ the Most Widely Used Automated Healthcare Hand Hygiene Monitoring System in the United States 2Proventix's nGage™ the Most Widely Used Automated Healthcare Hand Hygiene Monitoring System in the United States 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... learning, announced today that its RN to BSN and Master of Science ... full accreditation through June 2020 from the Commission on Collegiate Nursing Education ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... state-of-the-art digital press at its Denver facility that will usher in a new ... help Lightning Labels more effectively meet its twin objectives of quality ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... their partnership to make the Isabel Symptom Checker available to all users of ... a mechanism to check their symptoms in an easy, intuitive method, provides access ...
(Date:8/3/2015)... ... August 04, 2015 , ... The American Academy ... The new internationally peer-reviewed Guidelines were prepared by members of the AAT as ... in evaluating patients with dental-oral and systemic health-related complaints. , Thermography is ...
(Date:8/3/2015)... ... August 03, 2015 , ... Representatives with Health ... on its website. , “Our ‘Ask a Nutritionist’ feature on our website is a ... healthily,” said Liza Brisk, nutritionist and spokeswoman for Health Food Grocers. , Health Food ...
Breaking Medicine News(10 mins):Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 2Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 3Health News:Loyola University New Orleans Awarded Accreditation for its Online RN to BSN and MSN Programs 4Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 2Health News:American Academy of Thermology (AAT) Publishes First-Ever Guidelines for Oral-Systemic Thermography 3Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3
... HealthTransaction Network(R) keeps costs down and improves access ... connecting health care facilities ... HealthTransaction Network(R) is,creating the first-ever nationwide health care ... services to underserved populations at,affordable costs, the company ...
... prevalence of congenital heart disease (CHD) among in vitro ... general population, but there is an increasing risk of ... by Yale School of Medicine researchers. , Mert ... Obstetrics, Gynecology & Reproductive Sciences, will present the abstract ...
... Results and Enables Resident Care Teams to Boost Time with ... ... 31 Vocollect Healthcare Systems, Inc.,the leading provider of voice-assisted care, ... has,completed its enterprise-wide implementation of AccuNurse voice-assisted,care at all four of ...
... with a chronic disease or cancer have to contend ... anemia impedes the patient considerably in his or her ... to a large number of these patients to alleviate ... always effective, and not all patients respond to this ...
... Tigris Pharmaceuticals,Inc., a privately held drug development company, ... to its Board of Directors., Mr. Granadillo served ... until 2004 when he retired after 34 years of ... comprised of its top,seven executives. As Lilly,s top human ...
... 31 A scary question indeed.,We,re not talking about ... or First Aid, or even the Emergency Room physician ... the people who do the education,training and research and ... your life. Most research makes the average person,s head ...
Cached Medicine News:Health News:Buffalo Company Launches First-ever National Electronic Transaction Network to Improve Health Care Access for Uninsured and Underinsured 2Health News:Buffalo Company Launches First-ever National Electronic Transaction Network to Improve Health Care Access for Uninsured and Underinsured 3Health News:Congenital heart defects increasing among IVF twins 2Health News:Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care 2Health News:Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care 3Health News:Progress toward an alternative for EPO: Gas6 offers remedy where EPO fails today 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 3Health News:Who Decides How to Save Your Life? 2
... The Nidek's ophthalmic Nd: YAG laser ... featured system of superb versatility and clinical ... YAG Laser (1064nm),, Lightweight Model ,Further ... more convenient setting in your office.,, ...
... delivers a solid-state green laser ... and plugs into any standard ... and extreme portability, the unit ... Nidek Phaco Emulsification System CV-24000 ...
... technology is an effective angina ... with poor targets. Because it ... suites, the CO2 Heart Laser ... make timely operative decisions to ...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
Medicine Products: